LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that 47 presentations at the 2010 Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Boston from September 12-15 will cover recent research related to its marketed antibiotic, CUBICIN® (daptomycin for injection), as well as the company’s clinical and preclinical antibiotic programs. Included are 43 poster presentations and 4 slide presentations.
